What is Competitive Landscape of Steris Company?

Steris Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What is the competitive landscape for Steris?

The infection prevention and medical technology sector is dynamic, with challenges like HAIs and complex procedures. Steris plc, a leader in infection prevention and procedural products, is central to this evolving landscape, focusing on patient safety and clinical outcomes.

Founded in 1985, Steris has grown from its Ohio roots into a global provider of sterilization, surgical, and critical care solutions for healthcare, pharmaceutical, and medical device customers. Understanding its competitive position is key.

How does Steris stack up against its rivals? A look at its competitive landscape, including a Steris Porter's Five Forces Analysis, reveals its market standing.

STERIS plc demonstrates a robust market position within the infection prevention and sterilization sector, a standing reinforced by its consistent financial achievements and comprehensive product portfolio. The company's strategic focus on core strengths, including sterilization and surgical technologies, alongside critical care solutions, positions it as a leader serving healthcare facilities, pharmaceutical companies, and medical device manufacturers worldwide. This market presence is further solidified by its significant revenue generation and strategic portfolio adjustments, such as the divestiture of its Dental segment to concentrate on its primary business areas.

Fiscal Year 2024 Performance

STERIS reported total revenue of $5.5 billion for fiscal year 2024, a 12% increase year-over-year. The Healthcare segment, its largest revenue driver, achieved 13% constant currency organic revenue growth in fiscal 2024.

First Quarter Fiscal Year 2025 Update

In the first quarter of fiscal year 2025, STERIS generated $1.3 billion in revenue from continuing operations, an 8% increase from the prior year. Adjusted net income for the quarter was $201.7 million.

Geographic and Segmental Reach

Approximately 70% of STERIS's fiscal 2024 revenue originated from the U.S., with significant contributions from the UK and other international markets. The Applied Sterilization Technologies (AST) segment experienced 7% reported revenue growth in Q1 fiscal 2025.

Market Growth and Position

STERIS is a key player in the global infection control market, which is projected to expand from USD 51.0 billion in 2024 to USD 69.2 billion by 2029, at a CAGR of 6.3%. North America held the largest market share at 34.14% in 2024.

Key Competitive Factors

STERIS's market position is strengthened by its consistent revenue growth and strategic focus on its core sterilization and infection prevention offerings. The company's ability to adapt, as seen with its portfolio streamlining, highlights its proactive business strategy in a competitive environment.

• Strong financial performance with significant year-over-year revenue increases.
• Consistent double-digit growth in its crucial Healthcare segment.
• Strategic divestitures to enhance focus on core competencies.
• Leading position in a growing global infection control market.

STERIS's market analysis reveals a company deeply entrenched in providing essential solutions for sterile processing and infection prevention. Its competitive landscape includes numerous industry competitors, each vying for market share in specialized segments like healthcare sterilization and life sciences. Understanding the Competitors Landscape of Steris is crucial for evaluating its market position against key rivals such as Getinge and others specializing in medical device sterilization and sterile instrument management. The company's growth strategy appears focused on leveraging its established strengths in sterilization technologies and expanding its service-based revenue streams, particularly within the Applied Sterilization Technologies segment, which saw a notable 24% increase in capital equipment revenue in Q1 fiscal 2025. These factors contribute to STERIS's competitive advantages in infection prevention and its overall market share in critical areas of medical technology.

Steris SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The Steris competitive landscape is dynamic, featuring a mix of established global players and specialized niche providers. Understanding these Steris industry competitors is crucial for a thorough Steris market analysis.

Key direct rivals in infection prevention and sterilization services include Getinge AB, Ecolab, Inc., 3M Company, and Advanced Sterilization Products (ASP), a Fortive Corporation subsidiary. Other significant companies in this space are Sotera Health LLC, MMM Group, MATACHANA GROUP, Belimed AG, and Olympus Corporation.

Getinge AB

This Swedish company is a major competitor, especially in sterile reprocessing and infection control. Getinge offers sterilization and disinfection solutions comparable to Steris, and also competes in surgical workplace equipment.

Ecolab, Inc.

Ecolab provides comprehensive water, hygiene, and infection-prevention solutions. While its reach is broad across industries, its healthcare division directly challenges Steris's offerings in infection control.

3M Company

3M has a notable presence in the infection prevention market. Although its healthcare segment is more diversified, it still represents a competitive force in specific product areas.

Advanced Sterilization Products (ASP)

As part of Fortive Corporation, ASP is a direct competitor in sterilization technologies. Its focus on infection prevention solutions places it squarely against Steris's core business segments.

Sotera Health LLC

Sotera Health is another key player in the sterilization and infection control space. Its operations often align with Steris's market segments, making it a significant competitor.

Consolidation and Acquisitions

Steris's acquisition of Cantel Medical in January 2021 for $4.6 billion significantly bolstered its position in infection prevention. Similarly, Getinge's acquisition of Healthmark Industries Co. Inc. in October 2023 demonstrates the ongoing consolidation trend aimed at strengthening market presence.

Indirect and Emerging Competition

Beyond direct rivals, diversified medical device giants like Medtronic, Boston Scientific, and Johnson & Johnson pose indirect competitive threats. These companies have the potential to expand into Steris's established markets. Furthermore, new entrants utilizing advanced technologies such as UV-C disinfection robots and AI-driven disinfection systems are introducing novel competitive dynamics, challenging traditional approaches to sterile processing and infection prevention. Understanding these evolving market trends is vital for Steris's Marketing Strategy of Steris.

• Steris market share in healthcare sterilization is influenced by these varied competitors.
• Steris business strategy must account for both direct and indirect Steris key competitors.
• Steris market position against Getinge is a key area of focus in the sterilization sector.
• Steris advantages over rival sterilization companies are often tied to technological innovation and service integration.

Steris PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

What Gives Steris a Competitive Edge Over Its Rivals?

STERIS plc secures its competitive standing through a strategic blend of proprietary technologies, robust intellectual property, established brand recognition, and a significant global footprint. The company's deep-rooted expertise in infection prevention and sterilization technologies is a cornerstone of its advantage, enabling the delivery of advanced solutions that adhere to rigorous regulatory standards and bolster patient safety. This comprehensive approach to infection control is a key differentiator in the Steris competitive landscape.

The company's extensive product portfolio, which spans sterilization equipment, essential consumables, and vital services, represents a significant strength. Coupled with substantial investments in research and development, STERIS consistently introduces innovative products and demonstrates an agile response to the evolving demands of the healthcare sector. This commitment to innovation is central to its Steris business strategy.

Proprietary Technologies and IP

STERIS leverages its unique technologies and extensive intellectual property to create advanced solutions. This focus on innovation is crucial for maintaining its market position against Steris industry competitors.

Broad Product Portfolio and Services

A wide array of sterilization equipment, consumables, and services provides STERIS with a comprehensive offering. This broad scope allows the company to cater to diverse client needs within the healthcare sector.

Economies of Scale and Global Reach

STERIS benefits from significant economies of scale in manufacturing and distribution, ensuring efficient global supply chains. With approximately 70% of its fiscal 2024 revenue originating from the U.S., its strong North American presence supports its worldwide service delivery.

Recurring Revenue Streams

The company's emphasis on recurring revenue from consumables and services provides financial stability. In Q1 fiscal 2025, consumable revenue grew by 23% and service revenue by 14%, underscoring this advantage.

Operational Efficiency and Market Adaptability

STERIS's ability to reduce lead times and manage backlog, returning to pre-pandemic levels in fiscal 2024, showcases its operational strengths. This efficiency, combined with ongoing innovation in sterilization and surgical technologies, reinforces its leadership and supports its Growth Strategy of Steris.

• Continuous investment in R&D fuels product innovation.
• Strong global presence facilitates broad market access.
• Focus on recurring revenue enhances financial predictability.
• Operational efficiencies improve supply chain responsiveness.

Steris Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

What Industry Trends Are Reshaping Steris’s Competitive Landscape?

The infection prevention and medical device sector is experiencing a period of significant change, presenting both hurdles and prospects for companies like STERIS plc. A primary trend is the increasing adoption of stricter regulatory standards across the globe. In 2025, key modifications to the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) are influencing the industry, alongside new cybersecurity mandates and the EU AI Act. The latter classifies most AI-enabled medical devices as high-risk, requiring manufacturers to ensure their AI systems are secure, accurate, and transparent. This necessitates updates to quality management systems to align with these new guidelines, making compliance vital to avoid market access issues and penalties.

Technological advancements, including the integration of AI and machine learning into medical devices, the use of UV-C disinfection robots, and the development of touchless dispensing systems, are reshaping healthcare delivery and creating new market segments. While these innovations offer opportunities for product differentiation and improved effectiveness, they also bring increased regulatory scrutiny and greater responsibilities for MedTech companies. The global infection control market is anticipated to reach USD 69.2 billion by 2029. This growth is fueled by factors such as the high prevalence of Healthcare-Associated Infections (HAIs), rising surgical volumes, and an expanding geriatric population. Understanding the Steris competitive landscape requires acknowledging these dynamic forces.

Industry Trends Shaping the Steris Market Analysis

The infection prevention and medical device industry is characterized by evolving regulatory landscapes and rapid technological advancements. Companies must adapt to new standards and integrate innovative solutions to remain competitive.

Future Challenges for Steris and its Industry Competitors

Navigating complex global regulations, managing supply chain costs, and adapting to market volatility are significant challenges. These factors directly impact Steris's market position against Getinge and other sterilization companies.

Opportunities in the Steris Competitive Landscape

Developing advanced AI-powered solutions and expanding the portfolio of innovative infection control products present key opportunities. The increasing demand for single-use products and protective apparel also offers lucrative growth avenues.

Steris Business Strategy in a Dynamic Market

The company's strategy focuses on balanced revenue growth across all segments, continuous margin improvement, and leveraging its North American manufacturing base. This approach aims to mitigate external pressures like tariffs and enhance Steris's competitive advantages in infection prevention.

Key Differentiators and Market Position

STERIS's strategic focus on innovation, regulatory compliance, and operational efficiency is crucial for maintaining its market position against major rivals. The company's commitment to transparency, as seen in its upcoming fiscal 2026 Q1 results conference call on August 7, 2025, underscores its approach to stakeholder engagement.

• Adapting to evolving EU MDR and IVDR regulations.
• Integrating AI and machine learning into medical devices.
• Expanding the market for single-use products and protective apparel.
• Leveraging North American manufacturing for supply chain resilience.
• Maintaining transparency and investor communication for stakeholder trust.

Steris Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔